Print Page Current Date/Time: Monday 19th February 2018 - 06:24:55

Great Basin Scientific, Inc (OTC: GBSN)

Great Basin Scientific is a molecular diagnostics company dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. With a compelling customer-centric business model, no-cost instrumentation, simple workflow, low-cost assays and support included at no-charge, Great Basin removes the barriers typically found in adopting molecular diagnostics.


Great Basin Scientific is innovating molecular diagnostics.

We are dedicated to delivering the industry’s most simple, yet powerful sample-to-result molecular diagnostics platform that provides fast, multiple-pathogen diagnoses of infectious diseases.

Our technology empowers health providers with answers to quickly and accurately define a clear treatment path for improved patient outcomes, shorter hospital stays, and dollars saved in hospitalization costs per patient.

Our vision is to make molecular diagnostic testing so easy and cost-effective that every patient will be tested for every serious infection, thereby reducing misdiagnoses and significantly limiting the spread of infectious disease.

Recent Headlines

Recent Events and Presentations

There are no upcoming events at this time.

Management Team

Ryan Ashton

Co-founder and CEO

Mr. Ashton has extensive experience in driving successful marketing, sales, IPO and M&A strategies for advanced-technology companies. His experience includes serving as a senior vice president, sales and marketing at Megahertz—a publicly-held company with annual sales in excess of $150 Million; as a senior officer at Inari, a pre-IPO technology start-up; and as CEO of Printelligent Corporation. Mr. Ashton has a proven track record in successfully managing diverse teams of personnel—scientists, marketing, sales and administrative resources—in high-growth technology companies.

Jeffrey Rona

Chief Financial Officer

Mr. Rona is a seasoned executive in the healthcare and biotech industry, with over 20 years of experience in originating, structuring and executing corporate transactions and financings. Prior to joining Great Basin, he was chief business officer of GlobeImmune, a private biopharmaceutical company developing treatments for cancer and infectious diseases. He was vice president of Corporate Development at Corgentech, Inc., following its merger with AlgoRx Pharmaceuticals. Mr. Rona helped execute the transaction in his role as CFO of AlgoRx prior to the merger. Mr. Rona also served in the investment banking department of UBS Warburg, and as director of finance and corporate development at Agenus, where he was instrumental in its IPO. He started his career at Coopers & Lybrand. Mr. Rona has a B.S. in Accounting from Case Western Reserve University.

Robert D. Jenison

Senior Vice President, R&D and Chief Technology Officer

Mr. Jenison joined Great Basin Corporation from BioStar, an Inverness Medical Innovations Inc. company (formerly Thermo Electron), where he served as associate director of Research and Development. At BioStar, Jenison directed a team in developing rapid nucleic acid diagnostic assays, created and then executed the go-to-market strategy for the platform, and was nominated for the Thermo Electron Life and Laboratory sector’s Innovation Award for development of the CF genotyping test. Jenison has been awarded four patents based on his work with nucleic acid ligands and arrayed elements; furthermore his work has been published in numerous scientific journals. Jenison holds a bachelors degree in Chemistry from Revelle College, University of California at San Diego.

Sandra Nielsen

Senior Vice President, Sales, Marketing, and HR

Ms. Nielsen is a seasoned executive with extensive success in building and executing customer acquisition programs for high–growth technology start–ups. Nielsen joins Great Basin from Pearson PLC where she served as senior director of marketing for the Data Solutions business unit (formerly Edustructures). During her tenure at Edustructures, she created and implemented aggressive marketing and customer acquisition programs that positioned the company for purchase by Pearson. Prior to Pearson, Nielsen served as the senior director of marketing for Omniture where she executed programs that contributed to the company’s record–setting (100 percent year–over–year) revenue growth in preparation for the company’s 2006 IPO. Nielsen oversees commercial strategy, including the company’s global sales and marketing efforts, managing both the direct sales team as well as the distributor network, and leads the customer/technical support operations. Nielsen also oversees product management/lifecycle and user experience, as well as corporate communications, public relations, and branding.

Wesley C. Lindsey, Ph.D, MBA

Vice President, Product Development

Dr. Lindsey joins from Nanosphere, Inc. where he was the associate director of Assay Development, Infectious Disease. At Great Basin, Dr. Lindsey is responsible for the development of IVD (In Vitro Diagnostics) assays from feasibility to FDA 510(k) clearance and market, and for directing reagent manufacturing and quality control. He received his Ph.D. in Genetics and Molecular Biology from Emory University, Atlanta, Ga., and an MBA from Georgia State University.

Carlos B. González, Ph.D.

Vice President, Engineering

Dr. Carlos González joined Great Basin Scientific from Abbott Point of Care where he served as R&D Director of Instrument Development. Prior to Abbott POC he held positions in new technology development with Siemens Diagnostics, Abbott Pharmaceutical (now Abbvie), and Lawrence Livermore National Laboratories where he helped demonstrate real-time PCR on a chip with nL volumes. At Great Basin, Dr. Gonzalez is responsible for analyzer and cartridge systems development. He received his Ph.D. in Electrical Engineering from University of California at Davis.

Corporate Headquarters

420 E South Temple, Suite 520
Salt Lake City, UT 84111
Phone: 801-990-1055
Fax: 801-990-1051

Investor Relations Contact

D: 385-215-3372


This site includes forward-looking statement regarding events, trends and business prospects which may affect future operating results and financial position, including but not limited to statements regarding the Company’s business strategy and vision. Forward-looking statements involve risk and uncertainties, which could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risk and uncertainties include, but are not limited to: (i) the Company’s limited operating history and history or losses; (ii) the Company’s ability to develop and commercialize new products and the timing of commercialization; (iii) the Company’s ability to obtain capital when needed; and (iv) other risks set forth in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the most recent 10-K and 10-Q. These forward-looking statements speak only as of the date hereof and Great Basin Scientific specifically disclaims any obligation to update these forward-looking statements, except as required by law.